These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 38433334

  • 1. Pharmacokinetics of Envarsus in pediatric kidney transplant recipients - phase 1 pilot conversion study.
    Kim JJ, Lawless L, Marshall D, Maxted A, Lunn A, Mallik M, Williams A.
    Pediatr Transplant; 2024 Mar; 28(2):e14703. PubMed ID: 38433334
    [Abstract] [Full Text] [Related]

  • 2. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients.
    Bae EK, Chandran MM, Everitt MD, Benz E, Bock M.
    Clin Transplant; 2024 Aug; 38(8):e15417. PubMed ID: 39087462
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients.
    Herden U, Sterneck M, Buchholz BM, Achilles EG, Ott A, Fischer L.
    Immun Inflamm Dis; 2021 Dec; 9(4):1771-1780. PubMed ID: 34559956
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effectiveness and safety of the conversion to MeltDose® extended-release tacrolimus from other formulations of tacrolimus in stable kidney transplant patients: A retrospective study.
    Sánchez Fructuoso A, Ruiz JC, Franco A, Diekmann F, Redondo D, Calviño J, Serra N, Aladrén MJ, Cigarrán S, Manonelles A, Ramos A, Gómez G, González Posada JM, Andrés A, Beneyto I, Muñiz AL, Perelló M, Lauzurica R.
    Clin Transplant; 2020 Jan; 34(1):e13767. PubMed ID: 31815310
    [Abstract] [Full Text] [Related]

  • 12. Clinical Experience with Extended-Release Tacrolimus in Older Adult Kidney Transplant Recipients: A Retrospective Cohort Study.
    January SE, Hagopian JC, Nesselhauf NM, Progar K, Horwedel TA, Santos RD.
    Drugs Aging; 2021 May; 38(5):397-406. PubMed ID: 33755934
    [Abstract] [Full Text] [Related]

  • 13. Conversion from twice daily tacrolimus capsules to once daily extended-release tacrolimus (LCP-Tacro): phase 2 trial of stable liver transplant recipients.
    Alloway RR, Eckhoff DE, Washburn WK, Teperman LW.
    Liver Transpl; 2014 May; 20(5):564-75. PubMed ID: 24493215
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and Safety of Once-Daily LCP-Tacrolimus Versus Twice-Daily Immediate-Release Tacrolimus in Adult Hispanic Stable Kidney Transplant Recipients: Sub-Group Analysis from a Phase 3 Trial.
    Faravardeh A, Akkina S, Villicana R, Guerra G, Moten MA, Meier-Kriesche U, Stevens DR, Patel SJ, Bunnapradist S.
    Ann Transplant; 2021 Apr 16; 26():e929535. PubMed ID: 33859155
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Extended-release tacrolimus dosing and outcomes in pediatric and young adult transplant recipients - A single-center experience.
    Huang X, Hapgood K, Allan K, Pruette C, Goswami E.
    Pediatr Transplant; 2024 Feb 16; 28(1):e14611. PubMed ID: 37735900
    [Abstract] [Full Text] [Related]

  • 17. The use of LCP-Tacrolimus (Envarsus XR) in simultaneous pancreas and kidney (SPK) transplant recipients.
    Torabi J, Konicki A, Rocca JP, Ajaimy M, Campbell A, Azzi Y, Pynadath C, Liriano-Ward L, Akalin E, Kinkhabwala M, Graham JA.
    Am J Surg; 2020 Apr 16; 219(4):583-586. PubMed ID: 32122660
    [Abstract] [Full Text] [Related]

  • 18. Conversion of twice-daily tacrolimus to once-daily tacrolimus formulation in stable pediatric kidney transplant recipients: pharmacokinetics and efficacy.
    Min SI, Ha J, Kang HG, Ahn S, Park T, Park DD, Kim SM, Hong HJ, Min SK, Ha IS, Kim SJ.
    Am J Transplant; 2013 Aug 16; 13(8):2191-7. PubMed ID: 23734831
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A multi-center interventional study to assess pharmacokinetics, effectiveness, and tolerability of prolonged-release tacrolimus after pediatric kidney transplantation: study protocol for a prospective, open-label, randomized, two-phase, two-sequence, single dose, crossover, phase III b trial.
    Karaterzi S, Tönshoff B, Ahlenstiel-Grunow T, Baghai M, Beck B, Büscher A, Eifler L, Giese T, Lezius S, Müller C, Oh J, Zapf A, Weber LT, Pape L.
    Front Nephrol; 2024 Aug 16; 4():1331510. PubMed ID: 38444519
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.